Cargando…

Identification and treatment of T2-low asthma in the era of biologics

Currently, and based on the development of relevant biologic therapies, T2-high is the most well-defined endotype of asthma. Although much progress has been made in elucidating T2-high inflammation pathways, no specific clinically applicable biomarkers for T2-low asthma have been identified. The the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyriakopoulos, Chris, Gogali, Athena, Bartziokas, Konstantinos, Kostikas, Konstantinos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8181790/ https://www.ncbi.nlm.nih.gov/pubmed/34109244 http://dx.doi.org/10.1183/23120541.00309-2020

Ejemplares similares

The Diagnostic Role of Uric Acid to Creatinine Ratio for the Identification of Patients with Adverse Pulmonary Embolism Outcomes
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

Corticosteroids in COVID-19: one size does not fit all
por: Gogali, Athena, et al.
Publicado: (2021)

Asthma and Tobacco Smoking
por: Bellou, Vanesa, et al.
Publicado: (2022)

Hypercoagulable State in COPD-A Comprehensive Literature Review
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

A direct adverse effect of smoking
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

A 68-year-old man with haemoptysis and extensive ipsilateral lung infiltrates
por: Kyriakopoulos, Chris, et al.
Publicado: (2021)

The Role of Digital Tools in the Timely Diagnosis and Prevention of Acute Exacerbations of COPD: A Comprehensive Review of the Literature
por: Konstantinidis, Athanasios, et al.
Publicado: (2022)

Recurrent bilateral lung infiltrates in a patient with ulcerative colitis
por: Assioura, Antonia, et al.
Publicado: (2022)

Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
por: Exarchos, Konstantinos P., et al.
Publicado: (2022)

Correction to: Adherence and quality of life assessment in patients with asthma treatment with budesonide/formoterol via the Elpenhaler device: the COMPLETE study
por: Exarchos, Konstantinos P., et al.
Publicado: (2022)

Recent Advances of Artificial Intelligence Applications in Interstitial Lung Diseases
por: Exarchos, Konstantinos P., et al.
Publicado: (2023)

Evaluation of the Clinical Effectiveness of the Salmeterol/Fluticasone Fixed-Dose Combination Delivered via the Elpenhaler(®) Device in Greek Patients with Chronic Obstructive Pulmonary Disease and Comorbidities: The AEOLOS Study
por: Steiropoulos, Paschalis, et al.
Publicado: (2021)

Cardiovascular Disease and Chronic Obstructive Pulmonary Disease: Adding a Third Dimension to the ABE Global Initiative for Chronic Obstructive Lung Disease 2023 Chronic Obstructive Pulmonary Disease Classification
por: Kostikas, Konstantinos, et al.
Publicado: (2023)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Lactate dehydrogenase, COVID-19 and mortality
por: Bartziokas, Konstantinos, et al.
Publicado: (2021)

Validation of the portable Bluetooth® Air Next spirometer in patients with different respiratory diseases
por: Exarchos, Konstantinos P., et al.
Publicado: (2020)

Prothrombotic state in patients with stable COPD: an observational study
por: Kyriakopoulos, Christos, et al.
Publicado: (2021)

Author Correction: Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study
por: Koulouris, Nikolaos, et al.
Publicado: (2022)

Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study
por: Koulouris, Nikolaos, et al.
Publicado: (2022)

Blood Eosinophils as Biomarkers to Drive Treatment Choices in Asthma and COPD
por: Kostikas, Konstantinos, et al.
Publicado: (2018)

SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
por: Papaioannou, Andriana I., et al.
Publicado: (2022)

A Real-World Study on the Day and Night-Time Symptoms Among Greek COPD Patients Who Recently Initiated Treatment with Dual Bronchodilation: The DANICO Study
por: Kostikas, Konstantinos, et al.
Publicado: (2022)

The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?
por: Kostikas, Konstantinos, et al.
Publicado: (2016)

Can Leukotriene Receptor Antagonist Therapy Improve the Control of Patients with Severe Asthma on Biological Therapy and Coexisting Bronchiectasis? A Pilot Study
por: Quaranta, Vitaliano Nicola, et al.
Publicado: (2022)

Asthma in the Precision Medicine Era: Biologics and Probiotics
por: Chiu, Chiao-Juno, et al.
Publicado: (2021)

Severe T2-high asthma in the biologics era: European experts' opinion
por: Pavord, Ian, et al.
Publicado: (2019)

Reducing Tolerance for SABA and OCS towards the Extreme Ends of Asthma Severity
por: Bakakos, Petros, et al.
Publicado: (2022)

Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study
por: Tzanakis, Nikolaos, et al.
Publicado: (2021)

AN UNEXPECTED CASE OF BILATERAL INFILTRATES DURING THE COVID-19 PANDEMIC
por: EXARCHOS, K., et al.
Publicado: (2022)

Control of asthma in real life: still a valuable goal?
por: Papaioannou, Andriana I., et al.
Publicado: (2015)

Body Composition in Severe Refractory Asthma: Comparison with COPD Patients and Healthy Smokers
por: Minas, Markos, et al.
Publicado: (2010)

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

Clinical implications for Vascular Endothelial Growth Factor in the lung: friend or foe?
por: Papaioannou, Andriana I, et al.
Publicado: (2006)

Nonadherence in the era of severe asthma biologics and thermoplasty
por: Lee, Joy, et al.
Publicado: (2018)

Severe Asthma in the Era of Biologics: Continuous Challenges
por: Schoini, Pinelopi, et al.
Publicado: (2023)

Clinical relevance of circulating autoantibodies in idiopathic pulmonary fibrosis; A NAt hard to break
por: Kirgou, Paraskevi, et al.
Publicado: (2022)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations
por: Bartziokas, Konstantinos, et al.
Publicado: (2023)

Biological treatments for severe asthma
por: Jin, Hyun Jung
Publicado: (2020)

Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
por: Tsilogianni, Zoi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_03kh01meo8d5i6ido9vn45r34a